FDA Accepts NDA for Vepdegestrant in ESR1-Mutant ER+/HER2– Breast Cancer
13 September, 2025
Leveraging Networks to Deliver Novel Therapies to Community Populations
13 September, 2025
Data Show Disparities in HMA Use Among Myelodysplastic Syndrome Populations
13 September, 2025
Taking the Next Steps to Advance Supportive Care in Leukemia
13 September, 2025
FDA Supports Advancement of Roxadustat Trial for Anemia-Associated MDS
13 September, 2025
Expanding Cancer Trial Opportunities Into the “Heart” of the Community
13 September, 2025
Addressing The Future of CAR T-Cell Therapies in Multiple Myeloma
13 September, 2025
Defining the Role of Immune Therapy in Multiple Myeloma
13 September, 2025
New Leadership Presents “Good Opportunity” to Expand Community-Based Trials
13 September, 2025
Novel CAR T-Cell Therapies May Improve Outcomes Vs SOCs in Multiple Myeloma
13 September, 2025
📢
Advertisement
300x250 Banner
Recent Content
COPD Biologics: Early Treatment Insights
Pulmonology • 2 hours ago
Antihypertensive Medication Guidelines
Cardiology • 4 hours ago
Juvenile Arthritis Care Transition
Rheumatology • 6 hours ago